Ironwood Investment Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,631
| Closed | -$236K | – | 174 |
|
|
2024
Q3 | $236K | Buy |
+14,631
| New | +$236K | 0.11% | 139 |
|
|
2024
Q2 | – | Sell |
-5,894
| Closed | -$115K | – | 179 |
|
|
2024
Q1 | $115K | Buy |
5,894
+206
| +4% | +$4.02K | 0.06% | 166 |
|
|
2023
Q4 | $118K | Sell |
5,688
-283
| -5% | -$5.85K | 0.06% | 156 |
|
|
2023
Q3 | $190K | Sell |
5,971
-201
| -3% | -$6.39K | 0.12% | 145 |
|
|
2023
Q2 | $207K | Sell |
6,172
-123
| -2% | -$4.13K | 0.12% | 147 |
|
|
2023
Q1 | $263K | Buy |
6,295
+389
| +7% | +$16.2K | 0.16% | 133 |
|
|
2022
Q4 | $200K | Sell |
5,906
-732
| -11% | -$24.8K | 0.13% | 144 |
|
|
2022
Q3 | $327K | Buy |
6,638
+17
| +0.3% | +$837 | 0.23% | 121 |
|
|
2022
Q2 | $260K | Buy |
6,621
+3
| +0% | +$118 | 0.17% | 131 |
|
|
2022
Q1 | $244K | Buy |
6,618
+194
| +3% | +$7.15K | 0.13% | 147 |
|
|
2021
Q4 | $628K | Buy |
6,424
+7
| +0.1% | +$684 | 0.31% | 104 |
|
|
2021
Q3 | $801K | Buy |
6,417
+16
| +0.2% | +$2K | 0.42% | 84 |
|
|
2021
Q2 | $803K | Sell |
6,401
-151
| -2% | -$18.9K | 0.41% | 89 |
|
|
2021
Q1 | $889K | Buy |
6,552
+60
| +0.9% | +$8.14K | 0.47% | 75 |
|
|
2020
Q4 | $590K | Sell |
6,492
-179
| -3% | -$16.3K | 0.35% | 97 |
|
|
2020
Q3 | $496K | Sell |
6,671
-15
| -0.2% | -$1.12K | 0.35% | 101 |
|
|
2020
Q2 | $570K | Buy |
6,686
+3,923
| +142% | +$334K | 0.44% | 89 |
|
|
2020
Q1 | $200K | Buy |
+2,763
| New | +$200K | 0.2% | 131 |
|